205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
7.84%
Revenue growth 50-75% of MCHP's 10.82%. Martin Whitman would scrutinize if slower growth is temporary.
No Data
No Data available this quarter, please select a different quarter.
7.84%
Gross profit growth 50-75% of MCHP's 15.09%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.84%
Other expenses growth while MCHP reduces costs. John Neff would investigate differences.
7.84%
Operating expenses growth while MCHP reduces costs. John Neff would investigate differences.
7.84%
Total costs growth while MCHP reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.84%
EBITDA growth below 50% of MCHP's 144.00%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
7.84%
Operating income growth below 50% of MCHP's 132.00%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
-7.84%
Other expenses reduction while MCHP shows 29.56% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.14%
Net income decline while MCHP shows 87.97% growth. Joel Greenblatt would examine position.
-38.92%
Net margin decline while MCHP shows 89.14% growth. Joel Greenblatt would examine position.
-33.33%
EPS decline while MCHP shows 70.34% growth. Joel Greenblatt would examine position.
-33.33%
Diluted EPS decline while MCHP shows 70.34% growth. Joel Greenblatt would examine position.
0.64%
Share count reduction below 50% of MCHP's 0.33%. Michael Burry would check for concerns.
0.64%
Diluted share reduction below 50% of MCHP's 0.33%. Michael Burry would check for concerns.